The findings suggest that GLP-1 RAs could play a preventive role in reducing the risk of cirrhosis and related complications in patients with MASLD and diabetes, especially when initiated early in the disease course
These are the brand's own marketing and positioning statements, not independent rankings, lab-verified claims, or clinical findings by this publication
What this means in practice: a prospective patient can complete intake, pay the program fee, and still be determined medically ineligible by the clinician at Stage 2
Tirzepatide Efficacy: The SURMOUNT-1 trial showed that participants on the highest 15 mg dose achieved a mean weight reduction of 22.5% after 72 weeks
Role of phytochemicals as potential radioprotectants
Wegovy: Approved by the FDA on December 5, 2017, to lower blood sugar in people with type 2 diabetes and off-label for weight loss in people with obesity and overweight